PATENT CLAIM ANALYSIS

Application Number: 16420044
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "282000"]

Abstract:
Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.

Claim (Index 13):
The method of  claim 7 , wherein the stabilizing agent is ethylenediaminetetraacetic acid (EDTA) or a salt thereof.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 100.0
- Lexical Diversity: 1.38095
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16355525', '16023313', '15183441', '15890131', '14527613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7865894191528304
- 35 USC 102 Novelty (BERT): 0.5195412864795073
- Combined Prediction Score: 0.7598846058854981
- Mean Citation Score: 328.0028000000001
- Max Citation Score: 396.1192
- Similarity Product: 295.9338055244445

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test